Advocates Applaud DEA’s Fourth Extension of Remote Prescribing Flexibilities

Marissa Plescia / medcitynews - The DEA extended telemedicine prescribing flexibilities for controlled substances through the end of 2026, drawing praise from telehealth advocates who are urging a permanent solution.The post Advocates Applaud DEA’s Fourth Extension of Remote Prescribing…

AI Summary: The Drug Enforcement Administration has extended telemedicine prescribing flexibilities for controlled substances through 2026, maintaining the COVID-era approach. Telehealth advocates are cheering the move as it cements remote care as a long-term fixture, even as regulators and critics continue debating its broader safety implications.

#healthcare #pharmaceuticals #publichealth #governmentpolicy

Matt Sherer: We Need a Permanent Solution for Telehealth Access

4 months / oncodaily

Why a waiver extension is crucial for the Rural Health Transformation Program

4 months / beckershospitalreview / Andrew Cass

Provider, telehealth groups urge Congress to make telehealth flexibilities permanent

4 months / healthcaredive / Emily Olsen

Another Extension Expected for Virtual Prescribing, Same Uncertainty

4 months / medcitynews / Thomas R. Milam

AMA to Congress: Make Medicare Telehealth Services Permanent

4 months / medcitynews / Marissa Plescia

DEA, HHS extend telehealth controlled substance prescribing flexibilities for fourth time